Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bekir Dogan
Observed name:
Bekir Doğan
Institutions:
Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
Observed institutions:
Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
ORCID:
0000-0002-9542-445X
Observed ORCID:
0000-0002-9542-445X
OpenAlex ID:
A5135994907
Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study
2026
·
Sermin Dinc Sonusen
, Zehra Sucuoglu Isleyen
, et al.
·
Medicine
·
1
Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma
2026
·
Seher Yıldız Tacar
, Deniz Tural
, et al.
·
Tumori Journal
Author response for "Prognostic Value of CT Measured Baseline Tumor Volume in Nivolumab Treated Metastatic Renal Cell Carcinoma"
2026
·
Seher Yıldız Tacar
, Deniz Tural
, et al.
·
Publons reviews and discussion
Erythrocyte Transfusion as an Independent Predictor of Survival but Not Immune-Related Toxicity in Nivolumab-Treated Metastatic NSCLC: A Multicenter Cohort
2026
·
Mehmet Cem Fidan
, Ebru Çiçek
, et al.
·
Medicina
Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3–6 Month Relapse Window
2026
·
İbrahim Çil
, Maral Martin Mıldanoğlu
, et al.
·
Current Oncology
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
2026
·
Mustafa Seyyar
, Ali Kalem
, et al.
·
Current Oncology
PDF
Show more works
View as search
Works count:
6
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type